Reference ranges for serum S100B protein during the first three years of life

https://doi.org/10.1016/j.clinbiochem.2011.05.004Get rights and content

Abstract

Objective

Clinical and diagnostic management of traumatic brain injuries is problematic in young children. To facilitate this management, we describe blood reference ranges for the well established biomarker S100B in children younger than 3 years.

Design and methods

Serum S100B concentrations were determined by electro-chemiluminescence immunoassay in a population of 186 healthy children aged 0–3 years.

Results

Four age groups emerged, i.e. 0–3, 4–9, 10–24 and 25–36 months. We also found an interesting inverse correlation with head circumference.

Conclusion

This study provides useful serum S100B values from the largest cohort of healthy children aged 0–3 years old.

Introduction

The diagnosis of mild traumatic brain injury (mTBI) in babies and younger children (a very exposed population) is difficult. An alternative strategy to routine cranial computed tomography (CCT) based on biomarkers was developed [1], [2]. For this purpose, S100B protein appears to be the most sensitive and specific of the proposed biomarkers. Belonging to a multigenic family of calcium-binding proteins [3], S100B is predominantly expressed by cells of the central nervous system (mainly astroglial and also neuronal cells). Few recent works determined blood S100B values in children as a step towards validated ranges proposed for diagnosis and predicting the outcome of mTBI in this vulnerable population [4], [5]. Detailed (to month-group scale) reference ranges for children under 3 years of age have not yet been determined, mainly due to scattered data and limited patient numbers.

The aim of our study is to determine S100B serum levels in a large population of healthy children younger than 3 years old.

Section snippets

Material and methods

Two different centres recruited a pooled total of 236 healthy children seen during a routine consultation (males, n = 144; females, n = 92) whose ages ranged from 1 day to 16 years of age (mean = 2.7 years), with a majority (78%) younger than 3 years old. This study is in compliance with the Declaration of Helsinki ethical principles for medical research involving human subjects. The project was approved by the institutional ethics review boards of both hospitals. Written informed consent was obtained

Results

Serum S100B protein concentrations were measurable in all the children. S100B concentration in the global cohort of children aged 0–16 years old averaged 0.17 μg/L (SD 0.11; range 0.07–0.83) with no significant difference between males and females (p = 0.16), as previously described using the same technique [4]. S100B levels were moderately inversely correlated with age (r =  0.66; p < 0.001). Mean S100B concentration in children aged over 36 months (0.11 μg/L) was similar to that previously described [4]

Discussion

This is the first study to report reference ranges for serum S100B protein in what, to date, is the largest published population of healthy paediatric patients aged under 3 years old — a population highly exposed to traumatic brain injury. Protein S100B, neuron-specific enolase, and glial fibrillary acidic protein are the most commonly studied biomarkers, while protein S100B has been studied the most in the field of paediatric mTBI [1]. This biological information provides clinicians with help

Acknowledgments

The authors thank A.T.T (Auvergne Traduction Technique®) for proofreading the manuscript.

References (12)

There are more references available in the full text version of this article.

Cited by (38)

  • Interest of blood biomarkers to predict lesions in medical imaging in the context of mild traumatic brain injury

    2020, Clinical Biochemistry
    Citation Excerpt :

    Blood collection should take place within 3 h of trauma. Cut-off levels should be based on pediatric reference ranges [22,37,38] because S100B serum concentrations are higher at the beginning of life (Fig. 1). Glial fibrillary acid protein (GFAP) is a cytoskeletal protein belonging to the class of intermediate filaments specific for astrocytes [39].

  • Evaluation of the Roche® Elecsys and the Diasorin® Liaison S100 kits in the management of mild head injury in the emergency room

    2018, Clinical Biochemistry
    Citation Excerpt :

    The difference was exacerbated due to higher normal S100ß ranges in younger children and the higher proportion of younger children in the positive S100ß group (3 < 1 year old, 4 between 1 and 3 years old and 3 of 9 years old). A negative correlation has already been described in different reports relating normal range values according to age in children [7,12,18]. Within the negative S100ß group, based on symptoms and clinical examinations, 14 patients with a GCS of 15 were discharged without CT-scan and home monitoring was provided by parents/guardians.

  • Reference ranges for serum S100B neuroprotein specific to infants under four months of age

    2017, Clinical Biochemistry
    Citation Excerpt :

    The University Hospital of Nantes included infants prospectively from June 2014 to August 2016. In order to increase our sample size and enhance the power of our results, we combine our data to those from Bouvier et al. [6]. We included children under 4 months of age who had been admitted in Clermont-Ferrand and Graz (Centres 1 and 2) for routine surgical interventions or routine consultations, and in Nantes (Centre 3) to the paediatric emergency department for any reason other than head trauma (mainly fainting's, impaired growth, fever, gastrointestinal disorders).

  • The potentials and limitations of neuro-biomarkers as predictors of outcome in neonates with birth asphyxia

    2017, Early Human Development
    Citation Excerpt :

    Of the BMs considered here, S100B is one of the most thoroughly studied. Reference curves in different biological fluids (i.e. amniotic, cord and peripheral blood, urine, saliva) have been provided [31–38]. Results show that the protein is gestational age-, gender- and mode of birth delivery-dependent.

View all citing articles on Scopus
View full text